Stanley C. Erck
2011
In 2011, Stanley C. Erck earned a total compensation of $1.4M as President & CEO at Novavax, a 50% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $138,906 |
|---|---|
| Option Awards | $905,760 |
| Salary | $370,417 |
| Other | $1,187 |
| Total | $1,416,270 |
Erck received $905.8K in option awards, accounting for 64% of the total pay in 2011.
Erck also received $138.9K in non-equity incentive plan, $370.4K in salary and $1.2K in other compensation.
Rankings
In 2011, Stanley C. Erck's compensation ranked 4,422nd out of 10,747 executives tracked by ExecPay. In other words, Erck earned more than 58.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,422 out of 10,747 | 59th |
Division Manufacturing | 1,570 out of 3,960 | 60th |
Major group Chemicals And Allied Products | 323 out of 1,033 | 69th |
Industry group Drugs | 194 out of 781 | 75th |
Industry Biological Products, Except Diagnostic Substances | 31 out of 157 | 80th |
Source: SEC filing on April 30, 2012.
Erck's colleagues
We found six more compensation records of executives who worked with Stanley C. Erck at Novavax in 2011.
2011
Rahul ScD
Novavax
Chief Executive Officer
2011
Frederick Driscoll
Novavax
Chief Financial Officer
2011
Gregory Glenn
Novavax
Chief Medical Officer
2011
Russell Wilson
Novavax
SVP, Business Development
2011
John Trizzino
Novavax
Former SVP, Business Development
2011
Timothy Hahn
Novavax